Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin

Quercetin API Manufacturers & Suppliers

2 verified results
Get full market intelligence report
Get full market intelligence report
Full access. Full negotiation power All Quercetin data. Full access. Full negotiation power

Commercial-scale Suppliers

Distributor
Produced in  China
|

Employees: 50+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: ISO9001
|
CoA

All certificates

ISO9001
CoA
Producer
Produced in  China
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: coa

All certificates

coa
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Get full market intelligence report
Get full market intelligence report
€399,-
All Quercetin data. Full access. Full negotiation power
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Quercetin | CAS No: 117-39-5 | GMP-certified suppliers

A medication that is widely researched for its antioxidant and protective roles in managing oxidative stress across diverse experimental and preclinical health contexts.

Therapeutic categories

AntioxidantsBCRP/ABCG2 InhibitorsBenzopyransBiological FactorsChromonesCompounds used in a research, industrial, or household setting
Generic name
Quercetin
Molecule type
small molecule
CAS number
117-39-5
DrugBank ID
DB04216
Approval status
Experimental drug, Investigational drug

Product Snapshot

  • Oral small-molecule flavonoid typically supplied in tablet form
  • Investigated for antioxidant and anti-inflammatory applications across various research areas
  • Classified as experimental with no FDA or EMA approvals

Clinical Overview

Quercetin (CAS 117-39-5) is a plant‑derived flavonol characterized by a 3‑hydroxyflavone backbone and is widely distributed in fruits, vegetables, and botanical materials. It is structurally related to glycosylated derivatives such as rutin and quercetrin. In pharmaceutical research settings, quercetin is primarily investigated for its redox‑active properties and enzyme‑modulating effects, rather than for any formally established clinical indication.

Pharmacologically, quercetin functions as an antioxidant capable of interacting with reactive oxygen species and metal ions. It also inhibits multiple metabolizing enzymes and transporters, including several cytochrome P450 isoforms, catechol‑O‑methyltransferase, P‑glycoprotein, BCRP/ABCG2, OATP1B1, and OATP2B1. These interactions can affect experimental drug disposition models and are relevant when evaluating potential pharmacokinetic interactions in preclinical studies.

The mechanism of action most clearly defined for quercetin is inhibition of quinone reductase 2. This enzyme participates in the metabolic handling of quinolines in humans and in Plasmodium species. Inhibition in parasitic systems may promote oxidative stress, a proposed pathway for antiplasmodial activity in vitro. These mechanistic observations remain investigational and are not linked to an approved therapeutic use.

Absorption, distribution, metabolism, and excretion characteristics vary due to glycosylation state, intestinal metabolism, and extensive phase II conjugation. Oral bioavailability is generally limited and influenced by transporter interactions. Metabolites include glucuronide, sulfate, and methylated conjugates, which dominate systemic exposure.

Safety assessments indicate that quercetin exhibits dose‑dependent gastrointestinal effects and potential interactions with xenobiotic‑metabolizing enzymes. High concentrations in vitro have been associated with pro‑oxidant behavior, highlighting the importance of controlled experimental conditions. No established clinical safety profile exists for approved therapeutic use.

For API procurement, sourcing should prioritize authenticated botanical or synthetic origins, control of flavonoid profile, and compliance with impurities testing, residual solvent limits, and validated analytical methods suitable for complex polyphenolic materials.

Identification & chemistry

Generic name Quercetin
Molecule type Small molecule
CAS 117-39-5
UNII 9IKM0I5T1E
DrugBank ID DB04216

Pharmacology

SummaryQuercetin acts primarily as a quinone reductase 2 inhibitor, disrupting detoxification of quinoline metabolites and promoting oxidative stress in plasmodium. It interacts with a broad set of cellular proteins, including mitochondrial ATP synthase subunits, kinases, nuclear receptors, and metabolic enzymes. These combined target effects reflect its influence on redox balance, energy metabolism, and regulatory signaling pathways.
Mechanism of actionQuercetin is a specific quinone reductase 2 (QR2) inhibitor, an enzyme (along with the human QR1 homolog) which catalyzes metabolism of toxic quinolines. Inhibition of QR2 in plasmodium may potentially cause lethal oxidative stress. The inhibition of antioxidant activity in plasmodium may contribute to killing the malaria causing parasites.
Targets
TargetOrganismActions
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformHumans
UDP-glucuronosyltransferase 3A1Humans
ATP synthase subunit alpha, mitochondrialHumans

Formulation & handling

  • Low aqueous solubility may necessitate solubilization strategies such as solid dispersions or particle‑size reduction for oral formulations.
  • As a polyphenolic flavonol with multiple hydroxyl groups, it is prone to oxidation and may require antioxidant protection and controlled processing environments.
  • Solid‑state stability can be impacted by humidity, so low‑moisture excipients and protective packaging are typically preferred.

Regulatory status

Supply Chain
Supply chain summaryQuercetin is a naturally occurring flavonoid rather than a patented pharmaceutical, so there is no originator company or branded prescription product driving its supply landscape. It is produced and distributed globally as a dietary or nutritional ingredient, with packagers such as V Sab Medical Labs Inc. handling finished‑form packaging. Because it has no active patents, the market already functions as an open, multi‑supplier environment with broad generic competition.

Quercetin is a type of Herbal remedies


Herbal remedies, a subcategory of pharmaceutical active pharmaceutical ingredients (APIs), refer to medicinal products derived from plants. These remedies have been used for centuries in traditional medicine systems across various cultures worldwide. Herbal remedies harness the therapeutic properties of plant materials such as roots, leaves, flowers, and bark to treat a wide range of health conditions.

Herbal remedies are rich in bioactive compounds, including alkaloids, flavonoids, terpenes, and phenolic acids. These compounds exhibit diverse pharmacological activities and can provide benefits for various ailments. They may possess antioxidant, anti-inflammatory, antimicrobial, antiviral, or immunomodulatory properties, among others.

Pharmaceutical companies extensively research and develop herbal remedies to ensure their safety, efficacy, and standardization. The extraction and purification processes involve techniques such as solvent extraction, steam distillation, and chromatography. Quality control measures are implemented to maintain consistency and potency across batches.

Herbal remedies offer a natural alternative to conventional pharmaceutical drugs and are often preferred by individuals seeking holistic or complementary treatment options. They are commonly available in various forms, including capsules, tablets, tinctures, and topical formulations.

It is essential to note that while herbal remedies are generally considered safe, they can still have interactions with other medications and may not be suitable for everyone. Consulting with healthcare professionals or herbalists before starting any herbal treatment is recommended to ensure proper usage and avoid potential adverse effects.

Overall, herbal remedies within the pharmaceutical API subcategory provide a valuable option for individuals seeking natural alternatives and contribute to the growing field of plant-based medicine.


Quercetin (Herbal remedies), classified under Others


The others category refers to pharmaceutical APIs that do not fall under specific classifications such as antibiotics, antivirals, analgesics, or cardiovascular drugs. These APIs are diverse in nature and serve various therapeutic purposes, making them a crucial component of pharmaceutical formulations.

Pharmaceutical companies develop APIs in the others category to address specific medical conditions or target novel biological pathways. This category includes APIs used in oncology, neurology, immunology, and other specialized areas of medicine. The APIs in this category are often designed to interact with specific molecular targets or receptors, providing targeted therapeutic effects.

The development of APIs in the others category requires extensive research and testing to ensure their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers employ advanced techniques such as chemical synthesis, biotechnology, and genetic engineering to produce these APIs.

Due to the broad range of applications and therapeutic uses, APIs in the others category contribute significantly to the advancement of medical treatments. Pharmaceutical companies constantly strive to innovate and discover new APIs within this category to address unmet medical needs and improve patient outcomes.

In conclusion, the others category of pharmaceutical APIs encompasses a diverse range of active ingredients used in drug formulation. These APIs play a crucial role in developing innovative therapies across various therapeutic areas, contributing to advancements in healthcare and patient well-being.



Quercetin API manufacturers & distributors

Compare qualified Quercetin API suppliers worldwide. We currently have 2 companies offering Quercetin API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Producer
China China CoA23 products
Distributor
China China CoA, ISO9001764 products

When sending a request, specify which Quercetin API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Quercetin API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.

Frequently asked questions about Quercetin API


Sourcing

What matters most when sourcing GMP-grade Quercetin?
When sourcing GMP‑grade Quercetin, the key considerations are verifying that the supplier operates under appropriate GMP controls and can provide consistent quality and traceability for a natural‑origin ingredient. In an open, multi‑supplier market, confirming the manufacturer’s documentation, testing practices, and batch consistency is essential. It is also important to ensure the packager or distributor, such as those handling finished‑form packaging, maintains compliant handling and packaging processes.
Which documents are typically required when sourcing Quercetin API?
Request the core API documentation set: CoA (2 companies), ISO9001 (1 company). Confirm versions and validity dates match the destination market to avoid delays in qualification.
Which manufacturers are known to produce Quercetin API?
Known or reported manufacturers for Quercetin: Sinoway industrial Co.,Ltd. Evaluate their GMP history, scale, and regional coverage before requesting dossiers or allocating demand.
How can I request quotes for Quercetin API from GMP suppliers?
Submit quote requests through the supplier listings with your specs and required documents (specifications, target volume, delivery timeline, and destination). Providing consistent details upfront speeds comparable offers and clarifies technical feasibility.
Is a GMP audit report available for Quercetin manufacturers?
Audit reports may be requested for Quercetin: 0 GMP audit reports available. Confirm the scope and recency of any audit before relying on it for qualification decisions.
How many suppliers offer Quercetin API on Pharmaoffer?
Reported supplier count for Quercetin: 2 verified suppliers. Filter listings by certifications, regions, and delivery options to match your qualification plan.
Which countries are known to manufacture Quercetin API?
Production countries reported for Quercetin: China (2 producers). Knowing the manufacturing geography helps anticipate logistics lead times and import compliance needs.
Which certifications do suppliers of Quercetin usually hold?
Common certifications for Quercetin suppliers: CoA (2 companies), ISO9001 (1 company). Always verify issuing authorities and expiry dates when reviewing audit packages.

Technical

What is Quercetin (CAS 117-39-5) used for?
Quercetin is used in research settings as a flavonol probe for its antioxidant and redox‑active properties. It is commonly applied to study inhibition of quinone reductase 2 and its effects on cytochrome P450 enzymes, transporters, and other metabolizing systems. These activities make it useful for investigating oxidative stress mechanisms and potential pharmacokinetic interactions in preclinical models.
Which therapeutic class does Quercetin fall into?
Quercetin belongs to the following therapeutic categories: Antioxidants, BCRP/ABCG2 Inhibitors, Benzopyrans, Biological Factors, Chromones. This positioning helps teams compare alternative APIs, anticipate pharmacology expectations, and align early research priorities.
How does Quercetin work?
Quercetin is a specific quinone reductase 2 (QR2) inhibitor, an enzyme (along with the human QR1 homolog) which catalyzes metabolism of toxic quinolines. Inhibition of QR2 in plasmodium may potentially cause lethal oxidative stress. The inhibition of antioxidant activity in plasmodium may contribute to killing the malaria causing parasites.
What should someone know about the safety or toxicity profile of Quercetin?
Quercetin’s safety information comes mainly from preclinical assessments, which show dose‑dependent gastrointestinal effects and enzyme‑modulating activity that can alter xenobiotic metabolism. At high in‑vitro concentrations it may display pro‑oxidant behavior, underscoring the need for controlled experimental conditions. Its ability to inhibit multiple drug‑metabolizing enzymes and transporters indicates a potential for pharmacokinetic interactions in research settings. No clinically established safety profile exists because it is not an approved therapeutic agent.
What are important formulation and handling considerations for Quercetin as an API?
Quercetin’s low aqueous solubility often requires approaches such as solid dispersions or particle‑size reduction to achieve suitable dissolution in oral dosage forms. Its polyphenolic structure makes it susceptible to oxidation, so inclusion of antioxidants and controlled, low‑oxygen processing conditions are commonly needed. Because its solid‑state stability can be affected by humidity, low‑moisture excipients and protective packaging are preferred during formulation and storage.
Is Quercetin a small molecule?
Quercetin is classified as a small molecule. That classification shapes process design, impurity profiling, and analytical control strategies.
Are there special stability concerns for oral Quercetin?
Oral Quercetin presents stability challenges due to its low aqueous solubility, often requiring techniques such as solid dispersions or particle‑size reduction. Its polyphenolic structure makes it susceptible to oxidation, so antioxidant measures and controlled processing are typically needed. In addition, humidity can affect its solid‑state stability, making low‑moisture excipients and protective packaging important.

Pharmaoffer

How does Pharmaoffer’s Smart Sourcing Service help with Quercetin procurement?
Pharmaoffer's Smart Sourcing Service coordinates compliant suppliers, documentation, and competitive quotes for Quercetin. It centralizes outreach, follow-ups, and document validation to shorten procurement timelines.
Is Quercetin included in the PRO Data Insights coverage?
PRO Data Insights coverage for Quercetin: 1629 verified transactions across 351 suppliers and 240 buyers worldwide. Use the dataset to benchmark suppliers and monitor regulatory activity where available.
Where can I access the API market report for Quercetin?
Market report availability for Quercetin: Report Available. The report highlights demand trends, pricing drivers, and supplier landscape insights for procurement planning.